Valid Insight will be exhibiting at ISPOR Europe 2026 in Vienna from 9–11 November, presenting new research and contributing to expert discussions on health technology assessment (HTA), health economics and outcomes research (HEOR), and evidence generation.
Visit us at Booth 217 to meet our team and explore the latest developments in NICE decision-making, health economic modelling and the responsible use of artificial intelligence in HTA.
Our research posters at ISPOR Europe 2026
Poster HTA55: NICE appraisal critique and recommendation outcomes
Monday 9 November | Poster discussion: 12:30–13:30
Gareth Wynne-McHardy will present our research examining methodological critique in NICE technology appraisals and its relationship with health economic model characteristics and reimbursement recommendation outcomes.
The study explores how different aspects of economic modelling and evidence generation contribute to methodological scrutiny, with the aim of informing manufacturers’ pre-submission evidence strategies.
Full poster title: Prioritising Pre-Submission Investment: Associations Between Health Economic Model Characteristics and NICE TA Critique Burden and Recommendation Outcomes
Read the HTA55 research abstract
Poster HTA386: NICE ECD18 and the future of HTA modelling
Wednesday 11 November | Poster discussion: 09:00–10:00
Gareth will also present our research exploring NICE’s evolving approach to health economic modelling, including the introduction of reference case extensions under ECD18.
The study examines the implications of increasing model standardisation for manufacturers and considers the potential role of generative AI in supporting evidence generation and health economic modelling.
Full poster title: From Bespoke Models to Shared Infrastructure: NICE ECD18 and the Future of HTA Modelling
Read the HTA386 research abstract
Issue panel: Agentic AI governance
Agentic AI Governance: How to Balance Innovation and Guidance
Monday 9 November | 16:45–17:45
Amanda Hansson-Hedblom will join an expert panel exploring how organisations can responsibly adopt agentic AI in evidence generation while maintaining appropriate governance, validation and human oversight.
The discussion will examine the balance between innovation and methodological rigour, including how risk-based governance can support the adoption of AI-enabled workflows in HEOR and HTA.
Meet the Valid Insight team at Booth 217
Gerdi Strydom, Stephen Hall, Anna McCormick, Amanda Hansson Hedblom and Gareth Wynne-McHardy will be attending ISPOR Europe 2026.
We look forward to connecting with colleagues across the life sciences industry to exchange perspectives on evolving HTA requirements, evidence generation and market access challenges.
Visit us at Booth 217 from 9–11 November 2026, or book a meeting with our team to discuss your priorities in evidence generation, HTA and market access.
We look forward to seeing you in Vienna.